AAPL 224.685 0.6698% MSFT 384.02 0.4788% NVDA 111.255 1.0032% GOOGL 157.84 0.4902% GOOG 159.68 0.5035% AMZN 197.41 2.7268% META 591.11 0.872% AVGO 172.361 2.2793% LLY 810.84 0.6967% TSLA 279.91 4.2651% TSM 170.81 1.2868% V 346.97 0.179% JPM 246.49 1.1615% UNH 522.62 -0.0956% NVO 68.16 0.1911% WMT 89.86 1.1595% LVMUY 124.78 0.971% XOM 118.345 -0.5838% LVMHF 624.62 0.4212% MA 546.87 -0.299%
AAPL 224.685 0.6698% MSFT 384.02 0.4788% NVDA 111.255 1.0032% GOOGL 157.84 0.4902% GOOG 159.68 0.5035% AMZN 197.41 2.7268% META 591.11 0.872% AVGO 172.361 2.2793% LLY 810.84 0.6967% TSLA 279.91 4.2651% TSM 170.81 1.2868% V 346.97 0.179% JPM 246.49 1.1615% UNH 522.62 -0.0956% NVO 68.16 0.1911% WMT 89.86 1.1595% LVMUY 124.78 0.971% XOM 118.345 -0.5838% LVMHF 624.62 0.4212% MA 546.87 -0.299%

blue-chip

One Insurance Company Can Face Resistance at the Current Levels - MPL

Mar 26, 2025 | Team Kalkine
One Insurance Company Can Face Resistance at the Current Levels - MPL
Image source: shutterstock

MPL:ASX
Investment Type
Large-cap
Risk Level
Action
Rec. Price (AU$)

Medibank Private Ltd (ASX: MPL)

Medibank Private Limited (ASX: MPL) is an integrated healthcare company that provides private health insurance and health solutions in Australia. MPL also offers other insurance, including travel, pet, and life insurance, to make things easier for its customers.

Recommendation Rationale - SELL at AUD 4.420

Xxxxxx Xxxxxx Xxxxxx

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx

  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx
  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .   


Disclaimer-

Kalkine Equities LLC (“Kalkine”) provides general information about companies and their securities. The information contained in the reports, including any recommendations regarding the value of or transactions in any securities, does not take into account any of your investment objectives, financial situation or needs. Kalkine Equities LLC is not registered as an investment adviser in the U.S. with either the federal or state government. Before you make a decision about whether to invest in any securities, you should take into account your own objectives, financial situation and needs and seek independent financial advice. All information in our reports represents our views as at the date of publication and may change without notice.

NOTE - Halo Technologies Holdings Ltd. (Company) is a client of Kalkine Media Pty Ltd (Kalkine Media), an Australian affiliate of Kalkine. However, under no circumstances have Kalkine or its related entities been, directly or indirectly influenced in making any direct or implied rating/recommendation or related insights concerning Company as contained in this report, and no form of compensation is or will be received by Kalkine, Kalkine Media or Kalkine’s other related entities for the publication of this report.